SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001415889-16-006351
Filing Date
2016-07-01
Accepted
2016-07-01 16:09:01
Documents
2
Period of Report
2016-07-01

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY SCHEDULE 14A fpmipre14a_july2016.htm PRE 14A 190200
3 fluoropharma.jpg GRAPHIC 17066
  Complete submission text file 0001415889-16-006351.txt   214978
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 333-147193 | Film No.: 161746989
SIC: 2835 In Vitro & In Vivo Diagnostic Substances